Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis
In acute optic neuritis, magnetic resonance imaging (MRI) may help to confirm the diagnosis as well as to exclude alternative diagnoses. Yet, little is known on the value of optic nerve imaging for predicting clinical symptoms or therapeutic outcome. To evaluate the benefit of optic nerve MRI for pr...
Saved in:
Published in | PloS one Vol. 10; no. 1; p. e0113961 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
30.01.2015
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In acute optic neuritis, magnetic resonance imaging (MRI) may help to confirm the diagnosis as well as to exclude alternative diagnoses. Yet, little is known on the value of optic nerve imaging for predicting clinical symptoms or therapeutic outcome.
To evaluate the benefit of optic nerve MRI for predicting response to appropriate therapy and recovery of visual acuity.
Clinical data as well as visual evoked potentials (VEP) and MRI results of 104 patients, who were treated at the Department of Neurology with clinically definite optic neuritis between December 2010 and September 2012 were retrospectively reviewed including a follow up within 14 days.
Both length of the Gd enhancing lesion (r = -0.38; p = 0.001) and the T2 lesion (r = -0.25; p = 0.03) of the optic nerve in acute optic neuritis showed a medium correlation with visual acuity after treatment. Although visual acuity pre-treatment was little but nonsignificantly lower if Gd enhancement of the optic nerve was detected via orbital MRI, improvement of visual acuity after adequate therapy was significantly better (0.40 vs. 0.24; p = 0.04). Intraorbitally located Gd enhancing lesions were associated with worse visual improvement compared to canalicular, intracranial and chiasmal lesions (0.35 vs. 0.54; p = 0.02).
Orbital MRI is a broadly available, valuable tool for predicting the improvement of visual function. While the accurate individual prediction of long-term outcomes after appropriate therapy still remains difficult, lesion length of Gd enhancement and T2 lesion contribute to its prediction and a better short-term visual outcome may be associated with detection and localization of Gd enhancement along the optic nerve. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: Dr. Sebastian Berg reports personal fees from Biogen Idec, personal fees from Novartis, outside the submitted work. Dr. Iris Kaschka has nothing to disclose. Dr. Kathrin Utz reports grants from Novartis, grants from Biogen Idec, outside the submitted work. Dr. Konstantin Huhn reports personal fees from Biogen Idec, personal fees from Novartis, personal fees from Merck Serono, outside the submitted work. Dr. Alexandra Lämmer has nothing to disclose. Dr. Robert Lämmer has nothing to disclose. Dr. Anne Waschbisch reports grants, personal fees and non-financial support from Biogen Idec GmbH, grants, personal fees and non-financial support from Merck Serono GmbH, personal fees and non-financial support from Teva/Sanofi Aventis, grants and personal fees from Bayer Schering, outside the submitted work. Dr. Stephan Kloska has nothing to disclose. Dr. De-Hyung Lee has nothing to disclose. Dr. Arnd Dörfler has nothing to disclose. Dr. Ralf Linker received honoraria and travel support from Bayer, BiogenIdec, Genzyme, Merck Serono, Novartis, TEVA Pharma and Research Support from BiogenIdec, Merck Serono and Genzyme, outside the submitted work. The authors confirm that co-author Ralf Linker is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to PLOS ONE Editorial policies and criteria. These authors contributed equally to this work. Conceived and designed the experiments: SB RAL AD AW DL. Performed the experiments: SB IK RL KH DL AL. Analyzed the data: SB IK KU RAL SK AD. Contributed reagents/materials/analysis tools: RAL AD KU. Wrote the paper: SB RAL IK KU SK. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0113961 |